Manchester Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,239
| Closed | -$16K | – | 1023 |
|
|
2021
Q3 | $16K | Hold |
3,239
| – | – | ﹤0.01% | 542 |
|
|
2021
Q2 | $21K | Hold |
3,239
| – | – | ﹤0.01% | 438 |
|
|
2021
Q1 | $25K | Hold |
3,239
| – | – | ﹤0.01% | 422 |
|
|
2020
Q4 | $21K | Hold |
3,239
| – | – | ﹤0.01% | 421 |
|
|
2020
Q3 | $22K | Hold |
3,239
| – | – | ﹤0.01% | 376 |
|
|
2020
Q2 | $27K | Hold |
3,239
| – | – | ﹤0.01% | 406 |
|
|
2020
Q1 | $25K | Hold |
3,239
| – | – | ﹤0.01% | 406 |
|
|
2019
Q4 | $27K | Hold |
3,239
| – | – | ﹤0.01% | 415 |
|
|
2019
Q3 | $24K | Hold |
3,239
| – | – | ﹤0.01% | 419 |
|
|
2019
Q2 | $36K | Hold |
3,239
| – | – | ﹤0.01% | 404 |
|
|
2019
Q1 | $35K | Hold |
3,239
| – | – | ﹤0.01% | 450 |
|
|
2018
Q4 | $74K | Hold |
3,239
| – | – | 0.01% | 317 |
|
|
2018
Q3 | $60K | Hold |
3,239
| – | – | 0.01% | 342 |
|
|
2018
Q2 | $74K | Hold |
3,239
| – | – | 0.01% | 324 |
|
|
2018
Q1 | $92K | Hold |
3,239
| – | – | 0.01% | 291 |
|
|
2017
Q4 | $68K | Hold |
3,239
| – | – | 0.01% | 317 |
|
|
2017
Q3 | $59K | Hold |
3,239
| – | – | 0.01% | 321 |
|
|
2017
Q2 | $50K | Hold |
3,239
| – | – | 0.01% | 347 |
|
|
2017
Q1 | $56K | Hold |
3,239
| – | – | 0.01% | 338 |
|
|
2016
Q4 | $36K | Hold |
3,239
| – | – | 0.01% | 378 |
|
|
2016
Q3 | $51K | Hold |
3,239
| – | – | 0.01% | 356 |
|
|
2016
Q2 | $33K | Buy |
+3,239
| New | +$33K | ﹤0.01% | 404 |
|